Juergen Martens Net Worth

The estimated Net Worth of Juergen Martens is at least $3.48 Milión dollars as of 13 June 2016. Juergen Martens owns over 10,000 units of Neos Therapeutics Inc stock worth over $11,500 and over the last 19 years Juergen sold NEOS stock worth over $3,472,262.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Juergen Martens NEOS stock SEC Form 4 insiders trading

Juergen has made over 30 trades of the Neos Therapeutics Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently Juergen bought 10,000 units of NEOS stock worth $99,000 on 13 June 2016.

The largest trade Juergen's ever made was exercising 140,000 units of Neos Therapeutics Inc stock on 24 November 2014 worth over $236,600. On average, Juergen trades about 16,753 units every 50 days since 2006. As of 13 June 2016 Juergen still owns at least 10,000 units of Neos Therapeutics Inc stock.

You can see the complete history of Juergen Martens stock trades at the bottom of the page.

What's Juergen Martens's mailing address?

Juergen's mailing address filed with the SEC is 28903 NORTH AVENUE PAINE, , VALENCIA, CA, 91355.

Insiders trading at Neos Therapeutics Inc

Over the last 9 years, insiders at Neos Therapeutics Inc have traded over $796,275 worth of Neos Therapeutics Inc stock and bought 558,630 units worth $7,201,055 . The most active insiders traders include Jack W Schuler, James E Deerfield Mgmt L.P.... a Bryant Fong. On average, Neos Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $42,698. The most recent stock trade was executed by Richard I Eisenstadt on 12 December 2018, trading 5,000 units of NEOS stock currently worth $10,800.

What does Neos Therapeutics Inc do?

Complete history of Juergen Martens stock trades at Mannkind Corp a Neos Therapeutics Inc

Neos Therapeutics Inc executives and stock owners

Neos Therapeutics Inc executives and other stock owners filed with the SEC include:

• Gerald McLaughlin,
  President, Chief Executive Officer, Director
• Richard Eisenstadt,
  Chief Financial Officer, Treasurer
• John Limongelli,
  Senior Vice President, General Counsel and Corporate Secretary
• Alan Heller,
  Independent Chairman of the Board
• Linda Szyper,
  Independent Director
• John Schmid,
  Independent Director
• Gregory Robitaille,
  Independent Director
• Bryant Fong,
  Independent Director
• James Robinson,
  Independent Director
• Beth Hecht,
  Independent Director
• Vipin K Garg,
  President, CEO & Director
• Juergen Martens,
  Chief Tech/Operations Officer
• Thomas P Mc Donnell,
  Chief Commercial Officer
• Paul R Edick,
  Director
• Partners 2007, L.P.Presidio...,
  
• Dorothy Engelking,
  VP of Regulatory Affairs
• Mark Tengler,
  Chief Technology Officer
• Ralph Essex Capital Corp Ia...,
  
• Andrew G Delaware Street Ca...,
  
• Jack W Schuler,
  10% owner
• Venture Assoicates Ii Llcbu...,
  
• James E Deerfield Mgmt L.P....,